Tests in obese mice indicated the triple agonist was more powerful than dual agonists in correcting obesity and diabetes (Finan, Yang, Ottaway)
The most commonly reported side effects of GLP-1 medications are gastrointestinal symptoms like nausea, abdominal pain, and constipation
Fear of long-term effects: Given the ongoing discussions about risks in the medical community, some patients may have concerns about the long-term impact of GLP-1 medications, including dangerous adverse reactions as described on the FDA warning label, like acute kidney injury and hypoglycemia
Direct answer: Gastroparesis is a disorder in which the stomach empties food too slowly even though no physical blockage blocks the stomach outlet
Bisgaard LS, Bosteen MH, Fink LN, Srensen CM, Rosendahl A, Mogensen CK, Rasmussen SE, Rolin B, Nielsen LB, Pedersen TX
(Prior studies have simply found a link between taking a GLP-1 receptor agonist and drinking lessbut didnt go so far as to actually prove that the medications caused people to drink less.) The new study, which was published in JAMA Psychiatry, could result in a future treatment for the more than 28 million American adults who struggle with alcohol-use disorder (AUD)